CLM-2026-013607
Summit Endocrine Associates, Endocrinology. Service 2026-03-31 at office (POS 11). Received 2026-04-20.
Member
Resolved through the identity graph
- Member
- Samantha Bell
- Member ID
- UHC-53711-81
- Date of birth
- 1970-12-02
- Identity
- Verified4 records, confidence 1.00
- Claim record
- CLMCLM-428841
- Relationship
- Self, Tampa, FL
Coverage and accumulators
Found by member ID
- Plan
- MEDICARE-ADV-B MA group GRP-0921
- Coverage period
- 2021-08-01 to present
- Deductible
- $2,517.64 of $3,500.0072%
- Out-of-pocket maximum
- $971.03 of $7,000.0014%
- Copays
- office $25.00, specialist $50.00, emergency $150.00
- Physical therapy visits
- 22 of 20 used
Provider
Billing and rendering
- Billing provider
- Summit Endocrine AssociatesEndocrinology · taxonomy 207RE0101X
- NPI
- 3880544135
- Network
- In network
- Rendering NPI
- 4261261356
- Location
- Dallas, TX · TIN 38-9625016
- Authorisation / referral
- none / none
Service lines
CMS-1500: procedures, modifiers, units, charges and the pricing outcome per line
| Line | Code | Description | Mod. | Units | Dx | Billed | Allowed | Member | Plan | Line status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 99214 | Office visit, established patient, moderate complexity | — | 1 | 1 | $273.00 | $169.26 | $50.00 | $119.26 | Paid |
| 2 | 95251 | Continuous glucose monitoring, analysis | — | 1 | 1 | $193.00 | $119.66 | $0.00 | $119.66 | Paid |
| Totals | $466.00 | $288.92 | $50.00 | $238.92 | ||||||
- 1. E11.9 Type 2 diabetes mellitus without complicationsprincipal
- 2. E05.90 Thyrotoxicosis, unspecified
- Patient account
- PA-534032
- Frequency code
- 1 (original)
- Accident
- No
- DRG
- —
- Admit / discharge
- —
- Landed
- 2026-10-22 12:44
Rules engine
CLAIMS-ADJ v1: 11 checks, 0 needing attention
| Check | Result | Code | Detail |
|---|---|---|---|
| Member identity | Pass | Attached to MBR-004787 (verified, link confidence 1.00). | |
| Eligibility | Pass | Active on 2026-03-31: MEDICARE-ADV-B (MA), effective 2021-08-01. | |
| Timely filing | Pass | Received 20 days after service (limit 90). | |
| Duplicate check | Pass | No matching prior claim in the duplicate window. | |
| Prior authorisation | Pass | No line requires precertification. | |
| Provider network | Pass | In-network provider Summit Endocrine Associates (3880544135). | |
| Medical necessity | Pass | Diagnosis supports the procedures billed. | |
| Bundling (NCCI) | Pass | No bundling conflicts. | |
| Benefit limits | Pass | No limited benefit on this claim. | |
| Completeness | Pass | Required documentation present. | |
| High-dollar review | Pass | Within the auto-adjudication ceiling. |
Notes
Provider, system and examiner notes on this claim
- ClinicalProvider: Summit Endocrine Associates2026-03-31 15:49
Follow-up for type 2 diabetes mellitus without complications. Plan discussed, medications reconciled.
Attachments
Documents received with the claim
Explanation of benefits
What the member will see
Claim history
Every event on this claim, sealed in the audit chain
- Rules engineApproved2026-10-22 12:44Clean claim.
Other claims for this member
Same resolved identity
| Claim | Service | Provider | Billed | Status |
|---|---|---|---|---|
| CLM-2026-005884 | 2026-08-22 | Sunrise Internal Medicine Associates | $413.00 | Approved |
| CLM-2026-023318 | 2025-12-29 | Northgate Clinical Laboratories | $129.00 | Approved |
AI recommendation
assist mode · apac.amazon.nova-pro-v1:0
Examiner decision
Approved by Claims rules engine; an examiner may still override
Evaluation truth
Hidden label from the synthetic generator; never shown to the model
Clean claim, priced at contract rate.